log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

Tekijä Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Julkaistu 2010

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

Tekijä Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Julkaistu 2012

Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B(100) in patients with T2DM

Tekijä Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Julkaistu 2013

Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids

Tekijä Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Julkaistu 2014

The mixed benefit of low lipoprotein(a) in type 2 diabetes

Tekijä Hermans, Michel P., Ahn, Sylvie A., Rousseau, Michel F.
Julkaisussa Lipids Health Dis (2017)

Non-HDL-cholesterol as valid surrogate to apolipoprotein B(100 )measurement in diabetes: Discriminant Ratio and unbiased equivalence

Tekijä Hermans, Michel P, Sacks, Frank M, Ahn, Sylvie A, Rousseau, Michel F
Julkaistu 2011

Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies

Tekijä Hermans, Michel P., Bouenizabila, Evariste, Amoussou-guenou, Daniel K., Ahn, Sylvie A., Rousseau, Michel F.
Julkaisussa Cardiovasc Diabetol (2015)

1,25-Dihydroxyvitamin D to PTH(1–84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

Tekijä Gruson, Damien, Ferracin, Benjamin, Ahn, Sylvie A., Zierold, Claudia, Blocki, Frank, Hawkins, Douglas M., Bonelli, Fabrizio, Rousseau, Michel F.
Julkaisussa PLoS One (2015)